01-04-2008 | Original Article
A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer
Published in: International Journal of Clinical Oncology | Issue 2/2008
Login to get access